Summary
The product TREMILAD 150 mg/ml, manufactured by Driada Medical, underwent testing to verify its authenticity and potency. The sample, identified by batch number 129806, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of the following compounds:
- Trenbolone Enanthate: 47.25 mg/ml
- Trenbolone Hexahydrobenzylcarbonate: 48.15 mg/ml
- Trenbolone Acetate: 46.54 mg/ml
The combined concentration matches the label claim of 150 mg/ml, with a slight variance in individual ester concentrations. This product demonstrates an accurate composition of its trenbolone esters, adhering to its specifications.
The testing process was initiated on 6 January 2022, with the sample received on 7 January 2022, and the analysis completed on 9 January 2022. The sample was submitted and funded by Driada Medical, warranting careful scrutiny of the results. It is noted that the sample was retested twice for verification. This report is intended for educational and harm reduction purposes, helping users make informed decisions about the accuracy of anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Driada Medical
- Product Name: TREMILAD 150 mg/ml
- Active Ingredients: Trenbolone Enanthate, Trenbolone Hexahydrobenzylcarbonate, Trenbolone Acetate
- Batch Number: 129806
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #16171
- Testing Ordered: 6 January 2022
- Sample Received: 7 January 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Driada Medical
- Analysis Paid For By: Driada Medical
Testing Results
- Specification: 150 mg/ml (combined concentration as stated on the label)
- Measured Concentrations:
- Trenbolone Enanthate: 47.25 mg/ml
- Trenbolone Hexahydrobenzylcarbonate: 48.15 mg/ml
- Trenbolone Acetate: 46.54 mg/ml
- Total Combined Concentration: 141.94 mg/ml
- Accuracy: 94.63% (5.37% below the label claim)
Verification Details:
- Verification URL: https://janoshik.com/tests/16171_RL8JNVJ43W3P (opens in a new window)
- Originally Published: https://thinksteroids.com/community/posts/2910574/ (opens in a new window)
Evaluation of Manufacturer-Funded Testing
Since this test was both submitted and paid for by the manufacturer, Driada Medical, it is important to evaluate the findings with care. Manufacturer-funded testing may involve selective sample submission or implicit pressure on the laboratory. However, the lab, Janoshik Analytical, is recognized for its transparency and history of reliable analyses. Additionally, the retesting of this sample adds a layer of verification to the results.
While the product appears to meet its general specifications, independent testing by a third party would further validate these findings for consumer confidence.
Conclusion
This analysis highlights the importance of laboratory testing in verifying the content and quality of anabolic steroid products. The results show that TREMILAD 150 mg/ml is accurately formulated with a slight underdosage, though still within reasonable limits. This report serves as a valuable resource for harm reduction and educational purposes, helping individuals make safer, evidence-based decisions regarding the use of these substances.
Disclaimer: This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
